Archives for June 25th, 2018 - Page 2
Destiny Pharma names new non-executive director
Custom Synthesis, Destiny Pharm has consolidate its board with appointing Nick Rodgers as an independent Non-Executive Director with immediate effect. Rodgers has considerable Board experience...
Santhera’s Raxone Early Acces to Medicines Scheme renewed in UK
Custom Synthesis, Santhera Pharmaceuticals’s Raxone has been renewed in UK, as the nation’s Medicines and Healthcare products Regulatory Agency (MHRA) has renewed the Early Access...
Sandoz receives positive CHMP opinion for proposed biosimilar infliximab
Custom Synthesis, The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for marketing authorization...